Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$181.44 - $260.22 $402,071 - $576,647
-2,216 Reduced 3.77%
56,624 $14.2 Million
Q3 2023

Nov 21, 2023

BUY
$240.69 - $338.77 $874,186 - $1.23 Million
3,632 Added 6.58%
58,840 $14.2 Million
Q2 2023

Jul 28, 2023

SELL
$271.54 - $344.06 $4.02 Million - $5.1 Million
-14,822 Reduced 21.17%
55,208 $19 Million
Q1 2023

May 08, 2023

BUY
$220.43 - $278.69 $15.4 Million - $19.5 Million
70,030 New
70,030 $19.5 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.5B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.